DEVELOPMENT AND VALIDATION OF RP-HPLC ASSAY METHOD FOR VILDAGLIPTIN USING QBD APPROACH AND ITS APPLICATION TO FORCED DEGRADATION STUDIES
Journal Title: International Journal of Pharmaceutical Sciences and Drug Research - Year 2016, Vol 8, Issue 3
Abstract
The concept of Quality by design (QbD) has recently gained importance in the area of analytical method development and involves understanding of the critical factors and their interaction effects by a desired set of experiments. So, the present work describes the development of Reverse Phase-High Performance Liquid Chromatography (RP-HPLC) method by QbD approach using Design of Experiments and subsequent validation for analysis of Vildagliptin in bulk drug and its pharmaceutical formulation. An efficient experimental design based on systematic scouting of all three key components of the RP‐HPLC method (Buffer pH, Organic Phase-% acetonitrile, Organic Modifier-Methanol) is presented. The significance and interaction effects of these parameters on the response variables (Retention time and tailing factor) were evaluated through statistical analysis tools like Analysis of Variance (ANOVA) and plots which revealed the final chromatographic conditions of the method. The developed method was validated and Forced degradation studies were also carried out in order to determine the stability-indicating nature of the method. The chromatographic separation was achieved on Jasco CrestPack RP C18 (250 × 4.6 mm, 5μ) column using Buffer (pH 6): Acetonitrile: Methanol (70:10:20 v/v) as mobile phase and detection was done using Photo-Diode Array (PDA) detector at 210 nm. The developed method of Vildagliptin is linear over a range of 5-15μg/ml having correlation coefficient R2 value as 0.999. The %RSD for precision and accuracy of the method was found to be less than 2%. Forced Degradation studies revealed that the method was found to be stability-indicating. The results showed that the proposed method is suitable for the precise and accurate determination of Vildagliptin in bulk and its formulation.
Authors and Affiliations
Meetali M. Chaphekar, Purnima D. Hamrapurkar
Keywords
Related Articles
- EP ID EP625175
- DOI 10.25004/IJPSDR.2016.080306
- Views 109
- Downloads 0
ANTI-INFLAMMATORY EFFECT OF SIMVASTATIN-ASPIRIN COMBINATION
The aim of this study is to investigate the anti-inflammatory effects of simvastatin alone and in combination with aspirin, the most widely used analgesic, antipyretic and anti-inflammatory agent, and to evaluate the eff...
DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING HPTLC METHOD FOR DETERMINATION OF SOLIFENACIN SUCCINATE AS BULK DRUG AND IN TABLET DOSAGE FORM
A new simple, stability- indicating high performance thin layer chromatographic (HPTLC) method has been developed and validated for estimation of Solifenacin succinate in bulk and in tablet dosage form. The optimized mob...
FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF ONDANSETRON HYDROCHLORIDE USING PLANTAGO OVATA (ISAPGHULA) MUCILAGE AS NATURAL SUPER DISINTEGRATING AGENT
Mouth dissolving tablet is an innovative solid unit dosage form that overcome the problem of swallowing and provide rapid disintegration & dissolution to release the drug as soon as they come in contact with saliva,...
DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE FLOATING MICROSPHERES CONTAINING ROPINIROLE HCL
Current investigation was to develop gastro retentive floating microsphere for Ropinirole. These microspheres of Ropinirole were prepared by ionic gelation method with an aim of increasing the gastric residence time and...
HETERO-BINUCLEAR COMPLEXES OF LANTHANUM (III) USING BRIDGING N,N?-BIS(2-PYRIDYLMETHYL)OXAMIDE AND TERMINAL 1,10-PHENANTHROLINE: SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL EVALUATION
In the present study, hetero-binuclear La(III) complexes were newly synthesized using well known bridging ligand N,N′-bis(2-pyridylmethyl)oxamide (2PMO, 1) and “complexes as ligands” [Cu(2PMO)] (2) and [...